Antimicrobial resistance patterns in long term geriatric care: Implications for drug therapy

Drugs and Aging

Volumn 8, Issue 3, 1996, Pages 162-170

  Mao, Cheng An ^a,d   Siegler, Eugenia L ^b   Abrutyn, Elias ^c  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^b NEW YORK UNIVERSITY   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; BETA LACTAM ANTIBIOTIC; CEFALOTIN; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIFAMOLE; COTRIMOXAZOLE; MACROLIDE; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; BACTERIAL INFECTION; ENTEROCOCCUS; GERIATRICS; GRAM NEGATIVE BACTERIUM; HAND WASHING; HUMAN; INFECTION CONTROL; INTRAVENOUS DRUG ADMINISTRATION; LONG TERM CARE; MULTIDRUG RESISTANCE; NURSING HOME; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

EID: 0029933548     PISSN: 1170229X     EISSN: None     Source Type: Journal    
DOI: 10.2165/00002512-199608030-00002     Document Type: Review

References (66)

1. Garibaldi R, Brodine S, Matsumiya S. Infections among patients in nursing homes. Policies, prevalence, and problems. N Engl J Med 1981 ; 305: 731-5
2. Franson T, Duthie P, Cooper J, et al. Prevalence survey of infection and their predisposing factors at a hospital-based nursing home care unit. J Am Geriatr Soc 1986; 34: 95-100
3. Scheckler W, Peterson P. Infections and infection control among residents of eight rural Wisconsin nursing homes. Arch Intern Med 1986; 146: 1981-4
4. Alvarez S, Serventi I, Lorenz P. Nosocomial infections among patients in long-term facilities. J Gerontol 1988; 43: M9-16
5. Magaziner J, Tenney JH, DeForge B, et al. Prevalence and characteristics of nursing home-acquired infections in the aged. J Am Geriatr Soc 1991; 39: 1071-8
6. Katz PR, Beam TRJ, Brand F, et al. Antibiotic use in the nursing home physician practice patterns. Arch Intern Med 1990; 150: 1465-8
7. Shlaes DM, Currie-McCumber CA, Lehman MH. Introduction of a plasmid encoding the OHIO-1 beta-lactamase to an intermediate-care ward by patient transfer. Infect Control Hosp Epidemiol 1988; 9: 317-9
8. Strausbaugh LJ, Jackson C, Sewell DL, et al. Methicillin resistant Staphylococcus aureus in extended care facilities: experiences in a veterans' affairs nursing home and a review of the literature. Infect Control Hosp Epidemiol 1991; 12: 36-45
9. Gaynes RP, Weinstein RA, Chamberlin W, et al. Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med 1985; 145: 1804-7
10. Spratt BG. Resistance to antibiotics mediated by target alterations. Science 1994; 264: 388-93
11. Davis J. Another look at antibiotic resistance. J Gen Microbiol 1992; 138: 1553-9
12. Bush K. Characterization of beta-lactamases. Antimicrob Agents Chemother 1989; 33: 259-63
13. Shaw KJ, Rather PN, Hare RS, et al. Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microb Rev 1993; 57: 138-63
14. Davis J. Inactivation of antibiotics and the dissemination of resistance genes. Science 1994; 264: 375-82
15. Cohen SP, Hooper DC, Wolfson JS, et al. Endogenous active efflux of norfloxacin in susceptible Escherichia coli. Antimicrob Agents Chemother 1988; 32: 1187-91
16. Levy SB. Active efflux mechanisms for antimicrobial resistance. Antimicrob Agents Chemother 1992; 36: 695-703
17. Nikaido H. Prevention of drug access to bacterial targets: permeability barriers and active efflux. Science 1994; 264: 382-8
18. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob Agents Chemother 1993; 37: 1563-71
19. Hooper DC, Wolfson JS, Souza KS, et al. Mechanisms of quinolone resistance in Escherichia coli: characterization of nfxB and cfxB, two mutant resistance loci decreasing norfloxacin accumulation. Antimicrob Agents Chemother 1989; 33: 283-90
20. Courvalin P. Transfer of antibiotic resistance genes between Gram-positive and Gram-negative bacteria. Antimicrob Agents Chemother 1994; 38: 1447-51
21. Horan TC, White JW, Jarvis WR, et al. Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ 1986; 35: 17SS-29SS
22. Panilio AL, Culver DH, Gaynes RP, et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 1992; 13: 582-6
23. O'Toole RD, Drew L, Dahlgren BJ, et al. An outbreak of methicillin-resistance staphylococcus aureus infection. Observations in hospital and nursing home. JAMA 1970; 213: 257-63
24. Hsu CCS, Macaluso CP, Special L, et al. High rate of methicillin resistance of Staphylococcus aureus isolated from hospitalized nursing home patients. Arch Intern Med 1988; 148: 569-70
25. Frenay HM, Peerbooms PGH, van Leeuwen WJ, et al. Nursing homes: not a source of methicillin-resistant Staphylococcus aureus in the Netherlands [letter]. Clin Infect Dis 1994; 19: 213-4
26. Bradley SF, Terpenning MS, Ramsey MA, et al. Methicillin-resistant Staphylococcus aureus: colonization and infection in a long-term care facility. Ann Intern Med 1991; 115: 417-22
27. Feingold K, Siegler EL, Wu B, et al. Methicillin-resistant Staphylococcus aureus colonization in a new nursing home. Aging Clin Exp Res 1994; 6: 368-71
28. Muder RR, Brennen C, Wagner MM, et al. Methicillin-resistant staphylococcal colonization and infection in a long-term care facility. Ann Intern Med 1991; 114: 107-12
29. Reagan DR, Doebbeling BN, Pfaller MA, et al. Elimination of coincident Staphylococcus aureus nasal and hand carriage with intranasal application of mupirocin calcium ointment. Ann Intern Med 1991; 114: 101-6
30. Cederna JE, Terpenning MS, Ensberg M, et al. Staphylococcus aureus nasal colonization in a nursing home: eradication with mupirocin. Infect Control Hosp Epidemiol 1990; 11: 13-6
31. Kauffman CA, Terpenning MS, He X, et al. Attempts to eradicate methicillin-resistant Staphylococcus aureus from a long-term care facility with the use of mupirocin ointment. Am J Med 1993; 94: 371-8
32. Rahman M, Connolly S, Noble WC, et al. Diversity of staphylococci exhibiting high-level resistance to mupirocin. J Med Microbiol 1990; 33: 97-100
33. Rahman M, Noble WC, Cookson B. Mupirocin-resistant Staphylococcus aureus [letter]. Lancet 1987 Aug; 387
34. Mulligan ME, Murray-Leisure KA, Ribner BS, et al. Methicillin-resistant Staphylococcus aureus: a consensus review of the microbiology, pathogenesis, and epidemiology with implications for prevention and management. Am J Med 1993; 94: 313-28
35. Thomas JC, Bridge J, Waterman S, et al. Transmission and control of methicillin-resistant Staphylococcus aureus in a skilled nursing facility. Infect Control Hosp Epidemiol 1989; 10: 106-10
36. Ribner BS, Landry MN, Gholson GL. Strict versus modified isolation for prevention of nosocomial transmission of methicillin-resistant Staphylococcus aureus. Infect Control 1986; 7: 317-20
37. Brumfitt W, Hamilton-Miller J. Methicillin-resistant Staphylococcus aureus. N Engl J Med 1989; 320: 1188-96
38. Daum TE, Schaberg DR, Terpenning MS, et al. Increasing resistance of Staphylococcus aureus to ciprofloxacin. Antimicrob Agents Chemother 1990; 34: 1862-3
39. Schaberg DR, Culver DH, Gaynes RP. Major trends in the microbial etiology of nosocomial infection. Am J Med 1991; 91 (3B): 72S-5S
40. Pallares R, Pujol M, Pena C, et al. Cephalosporins as risk factor for nosocomial Enterococcus faecalis bacteremia. Arch Intern Med 1993; 153: 1581-6
41. Zervos MJ, Kauffman CA, Therasse PM, et al. Nosocomial infection by gentamicin-resistant Streptococcus faecalis. Ann Intern Med 1987; 106: 687-91
42. Murray BE. Minireview. Beta-lactamase-producing enterococci. Antimicrob Agents Chemother 1992; 36: 2355-9
43. Moellering RC, Korzeniowski OM, Sande MA, et al. Species-specific resistance to antimicrobial synergism in Streptococcus faecium and Streptococcus faecalis. J Infect Dis 1979; 140: 203-8
44. Zervos MJ, Terpenning MS, Schaberg DR, et al. High-level aminoglycoside resistant enterococci. Colonization of nursing home and acute care hospital patients. Arch Intern Med 1987; 147: 1591-4
45. Leclercq R, Derlot E, Duval J, et al. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988; 319: 157-61
46. Leclercq R, Derlot E, Weber M, et al. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium. Antimicrob Agents Chemother 1989; 33: 10-5
47. Shlaes DM, Bouvet A, Devine C, et al. Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256. Antimicrob Agents Chemother 1989; 33: 198-203
48. Livornese LL, Dias S, Samel C, et al. Hospital-acquired infection with vancomycin-resistant Enterococcus faecium transmitted by electronic thermometers. Ann Intern Med 1992; 117: 112-6
49. Terpenning MS, Bradley SF, Wan JY, et al. Colonization and infection with antibiotic-resistant bacteria in a long-term care facility. J Am Geriatr Soc 1994; 42: 1062-9
50. Michielsen W, Vandevondele D, Verschraegen G, et al. Bacterial surveillance cultures in a geriatric ward. Age Ageing 1993; 22: 221-6
51. Philippon A, Labia R, Jacoby G. Mini review. Extended-spectrum beta-lactamases. Antimicrob Agents Chemother 1989; 33: 1131-6
52. Chow JW, Fine MJ, Shales DM, et al. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy. Ann Intern Med 1991; 115: 585-90
53. Rice LB, Willey SHP, Medeiros AA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum beta-lactamases at a Massachusetts chronic care facility. Antimicrob Agents Chemother 1990; 34: 2193-9
54. Heikkila E, Sundstrom L, Huovinen P. Trimethoprim resistance in E. coli from a geriatric unit. Antimicrob Agents Chemother 1990; 34: 2013-5
55. Muder RR, Brennen C, Goetz AM, et al. Association with prior fluoroquinolone therapy of widespread ciprofloxacin resistance among Gram-negative isolates in a veterans affairs medical center. Antimicrob Agents Chemother 1991; 35: 256-8
56. Wingard E, Shales JH, Mortimer EA. Colonization and cross-colonization of nursing home patients with trimethoprim-resistant gram-negative bacilli. Clin Infect Dis 1993; 16: 75-81
57. Shales DM, Lehman M, Currie-McCumber CA, et al. Prevalence of colonization with antibiotic resistant Gram-negative bacilli in a nursing home care unit: the importance of cross-colonization as documented by plasmid analysis. Infect Control 1986; 7: 538-45
58. MacArthur RD, Lehman MH, Currie-McCumber CA, et al. The epidemiology of gentamicin-resistant Pseudomonas aeruginosa on an intermediate care unit. Am J Epidemiol 1988; 128: 821-7
59. Hofmann JH, Cetron MS, Farley MM, et al. The prevalence of drug-resistant Steptococcus pneumoniae in Atlanta. N Engl J Med 1995 Aug; 333: 481-6
60. Dawson S, Pallett A, Davidson A, et al. Outbreaks of multiresistant pneumococci [Letter]. J Hosp Infect 1992; 22: 328-9
61. Friedland IR, McCracken GH. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. N Engl J Med 1994; 331: 377-82
62. Fiebach N, Beckett W. Prevention of respiratory infections in adults. Arch Intern Med 1994; 28: 2545-57
63. Butler JC, Breiman RF, Campbell JF, et al. Pneumococcal polysaccharide vaccine efficacy: an evaluation of current recommendations. JAMA 1993; 270: 1826-31
64. McCue JD. Rationale for the use of oral fluoroquinolones as empirical treatment of nursing home infections. Arch Fam Med 1994; 3: 157-64
65. Centers for Disease Control. Prevention and control of influenza. Recommendations of the practices advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 1995; 44 (RR-3): 1-22
66. Belshe RB, Burk B, Newman F, et al. Resistance of influenza A virus amantadine and rimantadine: results of one decade of surveillance. J Infect Dis 1989; 159: 430-5